Schrodinger Inc
Change company Symbol lookup
Select an option...
SDGR Schrodinger Inc
DIDIY DiDi Global Inc
GOTU Gaotu Techedu Inc
EFC Ellington Financial Inc
FITB Fifth Third Bancorp
AWAY ETFMG Travel Tech ETF
CO Global Cord Blood Corp
KRP Kimbell Royalty Partners LP
VIRX Viracta Therapeutics Inc
ONFO Onfolio Holdings Inc
Go

Health Care : Health Care Technology | Small Cap Blend
Company profile

Schrodinger, Inc. has developed a physics-based software platform, which enables discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions and government laboratories around the world. The Company also leverages its software platform to advance collaborative programs and its own pipeline of therapeutics to address unmet medical needs. The Company operates through two segments: software and drug discovery. The software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on building a portfolio of preclinical and clinical programs, internally and through collaborations, which has advanced to various stages of discovery and development. The Company’s pipeline of drug discovery programs include MALT1, CDC7, Wee1, and SOS1/KRAS.

Closing Price
$22.05
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Below Average)
Volume:
416,727

10-day average volume:
513,201
416,727

SDGR's position in the Health Care Technology industry

Industry PeersSDGRSLP

Summary

Company ProfileSchrodinger, Inc. has developed a physics-based software platform, which enables discovery of molecules for drug development and materials applications. The software platform is used by...
Simulations Plus, Inc. is a developer of drug discovery and development software for mechanistic modeling and simulation, for machine-learning-based prediction of properties of molecules from their...
Go to SLP summary
52-Week Change

VS. INDUSTRY
-15.90%
-2.84%
Market Cap

VS. INDUSTRY
$1.6B
$806.7M
Beta

VS. INDUSTRY
--
0.5
Dividend Yield

VS. INDUSTRY
--
0.60%
P/E (TTM, GAAP)

VS. INDUSTRY
--
77.00x
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$170.3M
$53.5M
Profit Margin

VS. INDUSTRY
-89.67%
20.02%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
--
12.73%
Revenue Growth (TTM)

VS. INDUSTRY
36.45%
10.94%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.